Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “incobotulinumtoxinA”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Post-approval studies (Phase 4)Study completedNCT01276015
What this trial is testing

Spread And Effectiveness Of Botulinum Neurotoxin A In Spastic Equinus In Cerebral Palsy

Who this might be right for
Cerebral Palsy and Botulinum Toxin
Universita di Verona 18
Testing effectiveness (Phase 2)Study completedNCT02207946
What this trial is testing

Botulinum Toxin A to Treat Arm Tremor

Who this might be right for
Essential Tremor of the Upper Limbs
Merz Pharmaceuticals GmbH 30
Post-approval studies (Phase 4)Study completedNCT01486264
What this trial is testing

Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex

Who this might be right for
Cervical Dystonia
Merz Pharmaceuticals GmbH 283
Large-scale testing (Phase 3)Study completedNCT02002884
What this trial is testing

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy

Who this might be right for
Cerebral PalsySpasticity
Merz Pharmaceuticals GmbH 351
Large-scale testing (Phase 3)Study completedNCT00770211
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 271
Large-scale testing (Phase 3)Active Not RecruitingNCT03992404
What this trial is testing

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

Who this might be right for
Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
Merz Pharmaceuticals GmbH 603
Large-scale testing (Phase 3)UnknownNCT05623410
What this trial is testing

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 300
Not applicableStudy completedNCT01337024
What this trial is testing

Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and After Botulinum Neurotoxin Type A (BoNT/A) Intradetrusor Injections

Who this might be right for
Bladder Disorder, Neurogenic
Balgrist University Hospital 36
Large-scale testing (Phase 3)Study completedNCT01098019
What this trial is testing

Treatment of Notalgia Paresthetica With Xeomin

Who this might be right for
Notalgia Paresthetica
Innovaderm Research Inc. 20
Large-scale testing (Phase 3)Study completedNCT01896895
What this trial is testing

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

Who this might be right for
Bilateral Blepharospasm (BEB)
Merz Pharmaceuticals GmbH 61
Testing effectiveness (Phase 2)Study completedNCT03806933
What this trial is testing

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Aesthetics GmbH 241
Large-scale testing (Phase 3)Study completedNCT00694148
What this trial is testing

Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

Who this might be right for
Healthy
Merz Pharmaceuticals GmbH 108
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Post-approval studies (Phase 4)Study completedNCT03044080
What this trial is testing

Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot

Who this might be right for
Stroke RehabilitationStroke Rehabilitation Spasticity Management
Parc de Salut Mar 20
Testing effectiveness (Phase 2)Looking for participantsNCT07486830
What this trial is testing

IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction

Who this might be right for
Provoked Vestibulodynia
Center for Vulvovaginal Disorders 54
Large-scale testing (Phase 3)Study completedNCT02677805
What this trial is testing

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

Who this might be right for
Glabellar Frown Lines
Croma-Pharma GmbH 251
Testing effectiveness (Phase 2)UnknownNCT02668497
What this trial is testing

Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy

Who this might be right for
Parkinson's Disease
Western University, Canada 50
Testing effectiveness (Phase 2)Study completedNCT02188277
What this trial is testing

Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy

Who this might be right for
Cerebral PalsySpastic Paraplegia and HemiparesisEquine and Equinovarus Foot Deformation
Merz Pharmaceuticals GmbH 64
Large-scale testing (Phase 3)Study completedNCT03302871
What this trial is testing

Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A

Who this might be right for
Cerebral Palsy
Kocaeli University 40
Not applicableStudy completedNCT01042119
What this trial is testing

Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

Who this might be right for
Overactive Bladder Syndrome
University of Zurich 200
Next Page